ArticleTheranostics2026

Anti-cancer immune priming with β-radioligand therapy using a novel high affinity antibody selectively targeting the 4Ig-Isoform of B7-H3.

Sarah E Glazer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.